Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03042559 · ClinicalTrials.gov registry record · NA

Protonics Knee Brace Versus Hamstring Resisted Exercise (HRE) on Individuals With Patellofemoral Pain Syndrome

A NA study of Patellofemoral Pain Syndrome, sponsored by Loma Linda University.

Completed
Registry status
NA
Development phase
43
Enrollment target
1
Study location

NCT03042559 is a NA study of Patellofemoral Pain Syndrome that has completed, run by Loma Linda University. The registered enrollment target is 43 participants, below the 142-participant average among 10 other Patellofemoral Pain Syndrome trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03042559, a NA study of Patellofemoral Pain Syndrome, has completed, sponsored by Loma Linda University.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target
1
Study location

Study Summary

ProtonicsTM Knee brace has been suggested as an intervention for patients with patellofemoral pain syndrome (PFPS). However, the effectiveness of this knee brace compared to traditional conservative methods knee rehabilitation is lacking. The objective of this randomized controlled trial was to compare the effect of ProtonicsTM knee brace vs. sports cord on knee pain and function in patients with PFPS.

Interventions

  • DEVICE Protonics Knee brace
  • DEVICE Sports Cords

Study Locations (1)

California

  • Loma Linda University Health - Loma Linda

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2017-02-14
Est. Completion 2018-01-08
Phase NA

Sponsor

Loma Linda University

237 total trials

What the Registry Record Tells You About NCT03042559

The ClinicalTrials.gov registry entry for NCT03042559 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 142-participant average among 10 other Patellofemoral Pain Syndrome trials with a reported enrollment target (70% lower). The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Patellofemoral Pain Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Protonics Knee brace is the first listed.

NCT03042559 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03042559 about?

NCT03042559 is a clinical study titled "Protonics Knee Brace Versus Hamstring Resisted Exercise (HRE) on Individuals With Patellofemoral Pain Syndrome". ProtonicsTM Knee brace has been suggested as an intervention for patients with patellofemoral pain syndrome (PFPS). However, the effectiveness of this knee brace compared to traditional conservative methods knee rehabilitation is lacking. The objective of this randomized controlled trial was to comp...

What is the current status of trial NCT03042559?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2017-02-14. Estimated completion is 2018-01-08.

What conditions does trial NCT03042559 study?

This clinical trial studies the following conditions: Patellofemoral Pain Syndrome.

What interventions are being tested in trial NCT03042559?

The interventions under investigation include: Protonics Knee brace (DEVICE), Sports Cords (DEVICE).

Who is sponsoring clinical trial NCT03042559?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03042559 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Patellofemoral Pain Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.